Key result
A 36-year-old female with pulmonary artery angiosarcoma mimicking malignant fibrous histiocytoma underwent pneumonectomy and chemotherapy, remaining disease-free for 18 months before recurrence.
Case Report (n=1)
No
Pulmonary artery angiosarcoma is a rare, aggressive neoplasm that can mimic pleomorphic malignant fibrous histiocytoma and requires a high level of suspicion and broad immunohistochemical panel for accurate diagnosis.
Answers are grounded in this paper and cite their sources.
Requires IHC panel for pulmonary artery masses mimicking MFH; leaves open optimal therapy and surveillance in this rare sarcoma.
Primary sarcomas of the major blood vessels can be classified based on location in relationship to the wall or by histologic type. Angiosarcomas are malignant neoplasms that arise from the endothelial lining of the blood vessels; those arising in the intimal compartment of pulmonary artery are rare. We report a case of pulmonary artery angiosarcoma in a 36-year old female with pulmonary masses. The patient had no other primary malignant neoplasm, thus excluding a metastatic lesion. Gross examination revealed a thickened right pulmonary artery and a necrotic and hemorrhagic tumor, filling and occluding the vascular lumen. The mass extended distally, within the pulmonary vasculature of the right lung. Microscopically, an intravascular undifferentiated tumor was identified. The tumor cells showed expression for vascular markers VEGFR, VEGFR3, PDGFRa, FGF, Ulex europaeus, FVIII, FLI-1, CD31 and CD34; p53 was overexpressed and Ki67 proliferative rate was increased. Intravascular angiosarcomas are aggressive neoplasms, often associated with poor outcome.
No takes yet. Share an insight, caveat, or question.
Bohn et al. (2012) conducted a case report in Pulmonary artery angiosarcoma (n=1). Right pneumonectomy and ifosfamide-based chemotherapy was evaluated. A 36-year-old female with pulmonary artery angiosarcoma mimicking malignant fibrous histiocytoma underwent pneumonectomy and chemotherapy, remaining disease-free for 18 months before recurrence.
Synapse has enriched 10 related papers. Consider them for comparative context: